Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kohlmann

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Nutrition and Cancer|September 26, 2017
Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric JunctionThomas Kiefer, Dorothea Krahl, Kathrin Osthoff, et al.
Gastroenterology|September 18, 2017
Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent CohortsGeorg Beyer, Ujjwal M Mahajan, Christoph Budde, et al.
Schmerz (Berlin, Germany)|January 21, 2025
How does an intervention work?-English Version : Development of an effect model for a complex intervention to prevent recurring or persistent pain using the example of PAIN 2.0Ulrike Kaiser, Leonie Schouten, Greta Hoffmann, et al.
Schmerz (Berlin, Germany)|January 21, 2025
[How does an intervention work?-German Version. : Development of an effect model for a complex intervention to prevent recurring or persistent pain using the example of PAIN 2.0]Ulrike Kaiser, Leonie Schouten, Greta Hoffmann, et al.
Anticancer Research|April 3, 2020
Correlation of Ductoscopic and Histopathological Findings and Their Relevance as Predictors for Malignancy: A German Multicenter StudyRalf Ohlinger, Carolin Flieger, Wenke Hahndorf, et al.
Trials|October 28, 2025
PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany-updateSandra Meyer-Moock, Daniel Szczotkowski, Leonie Schouten, et al.
BMC Neurology|August 4, 2022
Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study)Thomas Platz, Thomas Kohlmann, Steffen Fleßa, et al.
Trials|February 23, 2024
PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in GermanySandra Meyer-Moock, Daniel Szczotkowski, Leonie Schouten, et al.
Scientific Reports|May 4, 2022
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infectionEik Schäfer, Christian Scheer, Karen Saljé, et al.
Nutrition Journal|July 25, 2012
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trialMatthias Kraft, Kathleen Kraft, Simone Gärtner, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Nutrition and Cancer|September 26, 2017
Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric JunctionThomas Kiefer, Dorothea Krahl, Kathrin Osthoff, et al.
Gastroenterology|September 18, 2017
Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent CohortsGeorg Beyer, Ujjwal M Mahajan, Christoph Budde, et al.
Schmerz (Berlin, Germany)|January 21, 2025
How does an intervention work?-English Version : Development of an effect model for a complex intervention to prevent recurring or persistent pain using the example of PAIN 2.0Ulrike Kaiser, Leonie Schouten, Greta Hoffmann, et al.
Schmerz (Berlin, Germany)|January 21, 2025
[How does an intervention work?-German Version. : Development of an effect model for a complex intervention to prevent recurring or persistent pain using the example of PAIN 2.0]Ulrike Kaiser, Leonie Schouten, Greta Hoffmann, et al.
Anticancer Research|April 3, 2020
Correlation of Ductoscopic and Histopathological Findings and Their Relevance as Predictors for Malignancy: A German Multicenter StudyRalf Ohlinger, Carolin Flieger, Wenke Hahndorf, et al.
Trials|October 28, 2025
PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany-updateSandra Meyer-Moock, Daniel Szczotkowski, Leonie Schouten, et al.
BMC Neurology|August 4, 2022
Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study)Thomas Platz, Thomas Kohlmann, Steffen Fleßa, et al.
Trials|February 23, 2024
PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in GermanySandra Meyer-Moock, Daniel Szczotkowski, Leonie Schouten, et al.
Scientific Reports|May 4, 2022
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infectionEik Schäfer, Christian Scheer, Karen Saljé, et al.
Nutrition Journal|July 25, 2012
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trialMatthias Kraft, Kathleen Kraft, Simone Gärtner, et al.
Pageof 17